Last reviewed · How we verify
NCT03071354
Improving Muscle Function in Nutritionally at Risk, Elderly Patients
NA trial testing HMB protein supplement (3g) in Muscle Weakness. Withdrawn.
22 May 2017
Quick facts
| Lead sponsor | Wake Forest University Health Sciences |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Start date | 1 May 2017 |
| Primary completion | 22 May 2017 |
| Estimated completion | 22 May 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- HMB protein supplement (3g)
- Nutritional Supplement — full drug profile →
Conditions studied
- Muscle Weakness — all drugs for Muscle Weakness →
- ICU-acquired Weakness — all drugs for ICU-acquired Weakness →
Sponsor
Wake Forest University Health Sciences
Who can join
65 and older, any sex, with Muscle Weakness or ICU-acquired Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators propose to conduct a randomized, control trial of β-hydroxy-β-methylbutyrate (HMB) supplementation in elderly patients (≥65 years of age) with acute respiratory failure, who are identified at high risk for malnutrition by ICU-specific nutritional risk scores. Patients will receive either 3g of HMB daily, or control, daily until day 28 following randomization (even if discharged).The investigators will measure functional outcomes using standard, validated measures prior and after discharge.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03071354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Weakness
Currently open trials in the same condition.
- NCT06998134 — Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults · recruiting
- NCT07103499 — Abdominal and Core Exercises on Respiratory Functions in Obese and Overweight Women (COREBREATH) · NA · recruiting
- NCT07292311 — Reliability of Muscle Strength and Activation Assessment Tools and Effects of an Online Therapeutic Exercise Program in · NA · active not recruiting
- NCT07026084 — Effects of Biofeedback-Guided Training on Muscle Strength and Postural Alignment in Upper Cross Syndrome. · NA · recruiting
- NCT06205147 — Effects of Elastic Band Resistance Exercise on Muscle Strength and Depression in Hospitalized Elderly. · NA · recruiting
Other Wake Forest University Health Sciences trials
Trials by the same sponsor.
- NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
- NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial · NA · not yet recruiting
- NCT06876896 — Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter · NA · recruiting
- NCT07227051 — Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity · NA · recruiting
- NCT07215624 — Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03071354 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wake Forest University Health Sciences
- Last refreshed: 5 February 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03071354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing